Efficacy of injections with Disci/Rhus toxicodendron compositum for chronic low back pain--a randomized placebo-controlled trial

Daniel Pach, Benno Brinkhaus, Stephanie Roll, Karl Wegscheider, Katja Icke, Stefan N Willich, Claudia M Witt, Daniel Pach, Benno Brinkhaus, Stephanie Roll, Karl Wegscheider, Katja Icke, Stefan N Willich, Claudia M Witt

Abstract

Background: The effectiveness of injection therapy for low-back pain is still debatable. We compared the efficacy of local injections of the homeopathic preparation Disci/Rhus toxicodendron compositum (verum) with placebo injections and with no treatment in patients with chronic low back pain.

Methodology/principal findings: In a randomized controlled partly double blind multicenter trial patients with chronic low back pain from 9 German outpatient clinics were enrolled and randomly allocated in a 1∶1∶1 ratio to receive subcutaneous injections (verum or placebo) into painful sites on the lower back over 12 treatment sessions within eight weeks, or no treatment (rescue pain medication with paracetamol or NSAIDs). All trial personnel and participants were masked to treatment allocation. The primary outcome measure was the average pain intensity over the last seven days on a visual analogue scale (0-100 mm, 0 = no pain, 100 = worst imaginable pain) after eight weeks. Follow-up was 26 weeks. Primary analysis was by intention to treat. Between August 2007 and June 2008, 150 patients were randomly allocated to three groups (51 verum, 48 placebo and 51 no treatment). The mean baseline-adjusted low back pain intensity at week eight was: verum group 37.0 mm (97.5% CI 25.3;48.8), no treatment group 53.0 (41.8;64.2), and placebo group 41.8 (30.1;53.6). The verum was significantly superior to no treatment (P = 0.001), but not to placebo (P = 0.350). No significant side effects were reported.

Conclusions/significance: The homeopathic preparation was not superior to placebo. Compared to no treatment injections resulted in significant and clinical relevant chronic back pain relief.

Trial registration: ClinicalTrials.gov NCT00567736.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Trial flow chart.
Figure 1. Trial flow chart.
*primary outcome parameter available and used for primary analysis.
Figure 2. Mean (with 95% confidence interval)…
Figure 2. Mean (with 95% confidence interval) pain intensity over the last 7 days (VAS) at week 8 (primary outcome) and at week 26.
Differences were statistically significant for the comparison of verum and no treatment group at 8 weeks (P

References

    1. Speed C. Low back pain. BMJ. 2004;328:1119–1121.
    1. Savigny P, Kuntze S, Watson P, Underwood M, Ritchie G, et al. Low Back Pain: early management of persistent non-specific low back pain. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2009. 235
    1. Chenot JF, Becker A, Niebling W, Kochen MM. Aktualisierung der DEGAM-Leitlinie Kreuzschmerzen. Z Allg Med. 2007;83:487–494.
    1. Koes BW, van Tulder MW, Thomas S. Diagnosis and treatment of low back pain. BMJ. 2006;332:1430–1434.
    1. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA. 1998;280:1569–1575.
    1. Eisenberg DM, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Verbreitung alternativmedizinischer Methoden in den USA. Forschende Komplementärmedizin. 1999:152–154.
    1. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, et al. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. NEnglJMed. 1993;328:246–252.
    1. Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. AnnInternMed. 2001;135:262–268.
    1. Härtel U, Volger E. Inanspruchnahme und Akzeptanz klassischer Naturheilverfahren und alternativer Heilmethoden in Deutschland - Ergebnisse einer repräsentativen Bevölkerungsstudie. ForschKomplementärmedKlassNaturheilkd. 2004;11:327–334.
    1. Ernst E, White A. The BBC survey of complementary medicine use in the UK. Complement TherMed. 2000;8:32–36.
    1. Hamre H, Witt C, Glockmann A, Ziegler R, Willich S, et al. Anthroposophic therapy for chronic depression: a four-year prospective cohort study. BMC Psychiatry. 2006;6:57.
    1. Hamre HJ, Witt CM, Glockmann A, Wegscheider K, Ziegler R, et al. Anthroposophic vs. conventional therapy for chronic low back pain: a prospective comparative study. Eur J Med Res. 2007;12:302–310.
    1. Staal JB, de Bie R, de Vet HC, Hildebrandt J, Nelemans P. Injection therapy for subacute and chronic low-back pain. Cochrane Database Syst Rev. 2008:CD001824.
    1. Huskisson EC. Measurement of pain. Lancet. 1974;2:1127–1131.
    1. Kohlmann T, Raspe H. Hannover Functional Questionnaire in ambulatory diagnosis of functional disability caused by backache. Rehabilitation. 1996;35:I–VIII.
    1. Bullinger M, Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Göttingen: Hogrefe; 1998. 135
    1. Dillmann U, Nilges P, Saile H, Gerbershagen HU. Behinderungseinschätzung bei chronischen Schmerzpatienten. Schmerz. 1994;8:100–110.
    1. Geissner E. [The Pain Perception Scale–a differentiated and change-sensitive scale for assessing chronic and acute pain]. Rehabilitation. 1995;34:XXXV–XLIII.
    1. Geissner E, Schulte A. Die Schmerzempfindungsskala (SES) Göttingen: Hogrefe; 1996. 134
    1. Cohen J. Statistical power analysis for the behavioral sciences. New Jersey: Lawrence Erlbaum; 1988. 567
    1. LeBars D, Villaneuva L, Willer JC, Boussahira D. Diffuse noxious inhibitory control (DNIC) in animals and man. AcupunctMed. 1991;9:47–56.
    1. Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications. Pain. 1979;6:305–327.
    1. Kaptchuk TJ. Powerful placebo: the dark side of the randomised controlled trial. Lancet. 1998;351:1722–1725.
    1. Cherkin DC, Sherman KJ, Avins AL, Erro JH, Ichikawa L, et al. A randomized trial comparing acupuncture, simulated acupuncture, and usual care for chronic low back pain. Arch Intern Med. 2009;169:858–866.
    1. Ostelo RW, Deyo RA, Stratford P, Waddell G, Croft P, et al. Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change. Spine (Phila Pa 1976) 2008;33:90–94.
    1. Yelland MJ, Glasziou PP, Bogduk N, Schluter PJ, McKernon M. Prolotherapy injections, saline injections, and exercises for chronic low-back pain: a randomized trial. Spine. 2004;29:9–16.
    1. Furlan A, Tulder M, Cherkin D, Tsukayama H, Lao L, et al. Acupuncture and dry-needling for low back pain. Cochrane Database Syst Rev. 2005:CD001351.
    1. Martensson L, Wallin G. Sterile water injections as treatment for low-back pain during labour: a review. AustN Z J ObstetGynaecol. 2008;48:369–374.
    1. Kushtagi P, Bhanu BT. Effectiveness of subcutaneous injection of sterile water to the lower back for pain relief in labor. Acta ObstetGynecol Scand. 2009;88:231–233.
    1. Goldman N, Chen M, Fujita T, Xu Q, Peng W, et al. Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nature Neuroscience. 2010;13:883–888.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir